Pharma Plus Laboratories Private Limited - Due diligence report

A 360° intelligence report on Pharma Plus Laboratories Private Limited: trust score, financial health, credit view, compliance, directors, g…

1997-10-27 New Delhi, Delhi Strike Off Unlisted Active Non-Compliant
Share
View plans Plan
PP Pharma Plus Laboratories Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pharma Plus Laboratories Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
29/100
Trust Score
Caution Indicated

Pharma Plus Laboratories Private Limited is assessed as Caution Indicated with a Trust Score of 29/100. Pharma Plus Laboratories Private Limited is a private limited indian non-government company incorporated in 1997, operating in the Trading sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 09 Jul 2026 from the latest processed filings. Pharma Plus Laboratories Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Caution
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
29/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
10/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
20/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 10/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2016 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
SHANTHI BOPPANA 01234567 Director 01/04/2018 6 yrs Approved
ENNAM CHANDERASEKHAR LAVANYA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • SHANTHI BOPPANA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 20
Growth signals & trust indicators
Operating for 28+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (10/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence19/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment24/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view25/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 6 events
30 Sep 2016
Last AGM held
Annual general meeting
31 Mar 2016
Latest balance sheet
Filed with ROC
10 Sep 2008
Director ceased
ENNAM CHANDERASEKHAR LAVANYA
06 Jan 2007
Director appointed
ENNAM CHANDERASEKHAR LAVANYA (Director)
27 Oct 1997
Incorporated
Registered with Roc Delhi
Director appointed
SHANTHI BOPPANA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 1 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2016 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rishi Agro Project Limited U01403WB2012PLC189033 Kolkata, West Bengal, India
Bartaman Infracon Limited U45400WB2011PLC163323 Kolkata, West Bengal, India
Ashrayapariwar Projects India Limited U70109WB2012PLC186019 Kolkata, West Bengal, India
Adjoin Infrastructure India Limited U45400WB2012PLC188767 Kolkata, West Bengal, India
Orbit Geological & Mining Services Private Limited U74999DL2015PTC277052 New Dehli, Delhi, India
Univera Wonder Holidays Limited U74999WB2011PLC171128 Kolkata, West Bengal, India
Khatuwala Impex Limited U51909WB2013PLC193021 Kolkata, West Bengal, India
Kriaroj Technologies Private Limited U72300UP2015PTC071575 Gautam Buddha Nagar, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pharma Plus Laboratories Private Limited before audits and certifications: compliance score 10/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pharma Plus Laboratories Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Pharma Plus Laboratories Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 29/100, distress signals and MSME payment-delay disclosures - know whether Pharma Plus Laboratories Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Pharma Plus Laboratories Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pharma Plus Laboratories Private Limited an active company?

Pharma Plus Laboratories Private Limited has MCA status “Strike Off” with a compliance score of 10/100 (Caution Indicated).

Is Pharma Plus Laboratories Private Limited financially healthy?

Pharma Plus Laboratories Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Pharma Plus Laboratories Private Limited?

Its overall Trust Score is 29/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pharma Plus Laboratories Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Pharma Plus Laboratories Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Pharma Plus Laboratories Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 10/100 (Caution Indicated).

Is it risky to lend to Pharma Plus Laboratories Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.